Susan Margolis, M.D.
NPI 1558397505 · Specialist · New York, NY
Enrolled with Medicare as Practitioner - Ophthalmology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Susan Margolis, M.D. is a Specialist provider in New York, NY (NPI 1558397505).
Provider details
- NPI number
- 1558397505
- Entity type
- Individual
- Primary specialty
- SpecialistOther Service Providers
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- No
- License
- 185693 (NY)
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
2,703 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Complete Exam of Visual System92014 | 714 | $140 |
| Extended Exam of the Back Part of the Eye With Optic Nerve Drawing92202 | 664 | $17 |
| Imaging of Retina92134 | 282 | $45 |
| Imaging of Optic Nerve92133 | 260 | $40 |
| Established Patient Problem Focused Exam of Visual System92012 | 232 | $100 |
| Exam of Visual Field With Extended Testing92083 | 170 | $71 |
| New Patient Complete Exam of Visual System |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 18 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Latanoprost | 163 | 38 |
| Cyclosporinebrand: Restasis | 124 | 49 |
| Prednisolone Acetate | 114 | 73 |
| Ofloxacin | 81 | 52 |
| Ketorolac Tromethamine | 69 | 46 |
| Timolol Maleate | 56 | 19 |
| Lifitegrastbrand: Xiidra | 48 | 20 |
| Bimatoprostbrand: Lumigan |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$102 across 4 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-06-23
- Last updated
- 2013-12-30
Frequently asked questions
- What is Susan Margolis's NPI number?
- Susan Margolis's National Provider Identifier (NPI) is 1558397505, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Susan Margolis's specialty?
- Susan Margolis is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).
- Where is Susan Margolis located?
- Susan Margolis's practice location on file with NPPES is 323 E 34th St, New York, NY 10016-4974.
- What is Susan Margolis's phone number?
- The practice phone number listed in the NPPES registry for Susan Margolis is (212) 981-7260.
- Does Susan Margolis accept Medicare?
- Susan Margolis is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Susan Margolis's NPI active?
- Yes — Susan Margolis's NPI (1558397505) is active in the NPPES registry as of the last update on 2013-12-30.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.